UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer

Medical oncology (Northwood, London, England), 2020-03, Vol.37 (3), p.19-19, Article 19

2020

Link zum Volltext

Verfügbarkeit prüfen

Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies

Journal of clinical medicine, 2022-10, Vol.11 (21), p.6254

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients

Pharmacological research, 2022-07, Vol.181, p.106290-106290, Article 106290

2022

Link zum Volltext

Verfügbarkeit prüfen

Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach

Pharmaceuticals (Basel, Switzerland), 2021-09, Vol.14 (10), p.995

2021

Link zum Volltext

Verfügbarkeit prüfen

All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma

Cancer chemotherapy and pharmacology, 2020-12, Vol.86 (6), p.841-846

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells

Investigational new drugs, 2020-02, Vol.38 (1), p.92-98

2020

Link zum Volltext

Verfügbarkeit prüfen

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma

Journal of clinical medicine, 2022-12, Vol.11 (23), p.7162

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11, 7162

Journal of clinical medicine, 2023-11, Vol.12 (22), p.7053

2023

Link zum Volltext

Verfügbarkeit prüfen

Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules

Cancer letters, 2024-06, Vol.591, p.216900-216900, Article 216900

2024

Link zum Volltext

Verfügbarkeit prüfen

Metronomic Chemotherapy in Elderly Patients

Current oncology reports, 2024-04, Vol.26 (4), p.359-376

2024

Link zum Volltext

Verfügbarkeit prüfen

Complete Remission of a Diffuse Large B-Cell Lymphoma in a Young Patient, with Severe Tuberous Sclerosis, Treated with Metronomic Chemotherapy and Ibrutinib: A Case Report

Chemotherapy (Basel), 2024-03, Vol.69 (1), p.40

2024

Link zum Volltext

Verfügbarkeit prüfen

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly/FRAIL Patients, with Diffuse Large B-Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.3796-3797

2022

Link zum Volltext

Verfügbarkeit prüfen

Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib

Biochemical pharmacology, 2024-01, Vol.219, p.115952-115952, Article 115952

2024

Link zum Volltext

Verfügbarkeit prüfen

Active metronomic vinorelbine schedules decrease plasma interleukin-2 levels in mice with Lewis lung carcinoma

Journal of chemotherapy (Florence), 2021-05, Vol.33 (3), p.198-202

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer

Pharmacological research, 2020-08, Vol.158, p.104920-104920, Article 104920

2020

Link zum Volltext

Verfügbarkeit prüfen

New antiproliferative agents derived from tricyclic 3,4‐dihydrobenzo[4,5]imidazo[1,2‐a][1,3,5]triazine scaffold: Synthesis and pharmacological effects

Archiv der Pharmazie (Weinheim), 2022-11, Vol.355 (11), p.e2200295-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics

Biochemical pharmacology, 2019-06, Vol.164, p.94-105

2019

Link zum Volltext

Verfügbarkeit prüfen

New antiproliferative agents derived from tricyclic 3,4‐dihydrobenzoimidazotriazine scaffold: Synthesis and pharmacological effects

Archiv der Pharmazie (Weinheim), 2022-11, Vol.355 (11)

2022

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase

ACS pharmacology & translational science, 2023-12, Vol.6 (12), p.1870-1883

2023

Link zum Volltext

Verfügbarkeit prüfen

Synergistic activity of linifanib and irinotecan increases the survival of mice bearing orthotopically implanted human anaplastic thyroid cancer

American journal of cancer research, 2020-01, Vol.10 (7), p.2120-2127

2020

Link zum Volltext

Verfügbarkeit prüfen

Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer

American journal of cancer research, 2022-01, Vol.12 (7), p.3347-3356

2022

Link zum Volltext

Verfügbarkeit prüfen

Case Report: Two Case Reports of Acute Myopericarditis After mRNA COVID-19 Vaccine

Frontiers in cardiovascular medicine, 2022-03, Vol.9, p.827237

2022

Link zum Volltext

Verfügbarkeit prüfen

403 Acute myopericarditis after mRNA COVID-19 vaccine

European heart journal supplements, 2021-12, Vol.23 (Supplement_G)

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)
Berichte
(1)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Pharmacology & Pharmacy
(11)
Oncology
(9)
Metronomic Chemotherapy
(7)
Humans
(6)
Chemotherapy
(5)
Synergism
(5)
Animals
(4)
Cancer Therapies
(4)
Medicine
(4)
Medicine & Public Health
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Apoptosis
(3)
Chemistry, Medicinal
(3)
Drug Dosages
(3)
Lymphoma
(3)
Male
(3)
Medical Prognosis
(3)
Mice
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer

Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies

Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients

Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach

All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma

Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma

Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11, 7162

Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules

A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients

Metronomic Chemotherapy in Elderly Patients

Complete Remission of a Diffuse Large B-Cell Lymphoma in a Young Patient, with Severe Tuberous Sclerosis, Treated with Metronomic Chemotherapy and Ibrutinib: A Case Report

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly/FRAIL Patients, with Diffuse Large B-Cell Lymphoma

Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib

Active metronomic vinorelbine schedules decrease plasma interleukin-2 levels in mice with Lewis lung carcinoma

Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer

New antiproliferative agents derived from tricyclic 3,4‐dihydrobenzo[4,5]imidazo[1,2‐a][1,3,5]triazine scaffold: Synthesis and pharmacological effects

Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics

New antiproliferative agents derived from tricyclic 3,4‐dihydrobenzoimidazotriazine scaffold: Synthesis and pharmacological effects

Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase

Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. IJ. Clin. Med./I 2022, I11/I, 7162

Synergistic activity of linifanib and irinotecan increases the survival of mice bearing orthotopically implanted human anaplastic thyroid cancer

Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer

Case Report: Two Case Reports of Acute Myopericarditis After mRNA COVID-19 Vaccine

403 Acute myopericarditis after mRNA COVID-19 vaccine

Suchergebnisse filtern